Practice question

Answer the question and get instant feedback.

HardCardiologyHeart failure with reduced ejection fraction - SGLT2 inhibitorsau-amcau-racp

A 64-year-old man with HFrEF (EF 30%), NYHA class III symptoms and type 2 diabetes is on optimal doses of ACE inhibitor, beta blocker and mineralocorticoid receptor antagonist. His eGFR is 55 mL/min/1.73 m² and potassium is normal. According to current evidence, which additional medication class would most improve his prognosis?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.